Veracyte Files 8-K for 'Other Events' and Exhibits
Ticker: VCYT · Form: 8-K · Filed: Feb 29, 2024 · CIK: 1384101
| Field | Detail |
|---|---|
| Company | Veracyte, Inc. (VCYT) |
| Form Type | 8-K |
| Filed Date | Feb 29, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, other-events
TL;DR
**Veracyte filed a standard 8-K, nothing major to see here yet.**
AI Summary
Veracyte, Inc. filed an 8-K on February 29, 2024, reporting 'Other Events' and 'Financial Statements and Exhibits'. The filing indicates no specific material events or financial changes, but rather serves as a general update or placeholder for potential future disclosures. The company, based in South San Francisco, California, operates in medical laboratories and has a business phone number of (650) 243-6300.
Why It Matters
This 8-K filing is a routine disclosure, indicating that Veracyte, Inc. is keeping its public records updated, though it doesn't reveal any immediate significant news or changes for investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for 'Other Events' and 'Financial Statements and Exhibits' without specific material disclosures, indicating no immediate new risks.
Key Players & Entities
- VERACYTE, INC. (company) — Registrant
- South San Francisco, California (company) — Business address location
- February 29, 2024 (date) — Date of earliest event reported
- 001-36156 (company) — Commission File Number
- (650) 243-6300 (company) — Registrant's telephone number
FAQ
What is the purpose of this 8-K filing by Veracyte, Inc.?
This 8-K filing by Veracyte, Inc. is categorized under 'Other Events' and 'Financial Statements and Exhibits', indicating a general update or placeholder for potential future disclosures rather than a specific material event.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on February 29, 2024.
What is Veracyte, Inc.'s business address and phone number?
Veracyte, Inc.'s business address is 6000 Shoreline Court, Suite 300, South San Francisco, California 94080, and its telephone number is (650) 243-6300.
What is Veracyte, Inc.'s Commission File Number?
Veracyte, Inc.'s Commission File Number is 001-36156.
What is the Standard Industrial Classification (SIC) for Veracyte, Inc.?
Veracyte, Inc.'s Standard Industrial Classification (SIC) is SERVICES-MEDICAL LABORATORIES [8071].
Filing Stats: 507 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-02-29 17:27:02
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share VCYT The Nasdaq Stock Mar
Filing Documents
- d799495d8k.htm (8-K) — 25KB
- d799495dex51.htm (EX-5.1) — 10KB
- g799495g0227131557931.jpg (GRAPHIC) — 14KB
- 0001193125-24-053689.txt ( ) — 177KB
- vcyt-20240229.xsd (EX-101.SCH) — 3KB
- vcyt-20240229_lab.xml (EX-101.LAB) — 18KB
- vcyt-20240229_pre.xml (EX-101.PRE) — 11KB
- d799495d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 5.1 Opinion of Fenwick & West LLP. 23.1 Consent of Fenwick & West LLP (contained in Exhibit 5.1). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: February 29, 2024 VERACYTE, INC. By: /s/ Rebecca Chambers Name: Rebecca Chambers Title: Chief Financial Officer